Clarke, Ed <br/><br/>
Safety and immunogenicity of a novel 10-valent pneumococcal conjugate vaccine candidate in adults, toddlers, and infants in The Gambia-Results of a phase 1/2 randomized, double-blinded, controlled trial.  [electronic resource] 

 -  Vaccine  01 2020 
 - 399-410 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-2518 
<br/><br/><label>Standard No.: </label>10.1016/j.vaccine.2019.08.072  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Double-Blind Method<br/>Female<br/>Gambia<br/>Humans<br/>Immunization Programs<br/>Immunization Schedule<br/>Immunization, Secondary--methods<br/>Infant<br/>Male<br/>Pneumococcal Infections--immunology<br/>Pneumococcal Vaccines--administration & dosage<br/>Vaccination<br/>Young Adult